Literature DB >> 27749662

Perinatal Antiretroviral Exposure and Prevented Mother-to-child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.

Kristen M Little1, Allan W Taylor, Craig B Borkowf, Maria C B Mendoza, Margaret A Lampe, Paul J Weidle, Steven R Nesheim.   

Abstract

OBJECTIVES: Using published, nationally-representative estimates, we calculated the total number of perinatally HIV-exposed and HIV-infected infants born during 1978-2010, the number of perinatal HIV cases prevented by interventions designed for the prevention of mother-to-child transmission (PMTCT), and the number of infants exposed to antiretroviral (ARV) drugs during the prenatal and intrapartum periods.
DESIGN: We calculated the number of infants exposed to ARV drugs since 1994, and the number of cases of mother-to-child HIV transmission prevented from 1994 to 2010 using published data. We generated confidence limits for our estimates by performing a simulation study.
METHODS: Data were obtained from published, nationally-representative estimates from the Centers for Disease Control and Prevention. Model parameters included the annual numbers of HIV-infected pregnant women, the annual numbers of perinatally infected infants, the annual proportions of infants exposed to ARV drugs during the prenatal and intrapartum period and the estimated MTCT rate in the absence of preventive interventions. For the simulation study, model parameters were assigned distributions and we performed 1,000,000 repetitions.
RESULTS: Between 1978 and 2010, an estimated 186,157 [95% confidence interval (CI): 185,312-187,003] HIV-exposed infants and approximately 21,003 (95% CI: 20,179-21,288) HIV-infected infants were born in the United States. Between 1994 and 2010, an estimated 124,342 (95% CI: 123,651-125,034) HIV-exposed infants were born in the US, and approximately 6083 (95% CI: 5931-6236) infants were perinatally infected with HIV. During this same period, about 100,207 (95% CI: 99,374-101,028) infants were prenatally exposed to ARV drugs. As a result of PMTCT interventions, an estimated 21,956 (95% CI: 20,191-23,759) MTCT HIV cases have been prevented in the United States since 1994.
CONCLUSION: Although continued vigilance is needed to eliminate mother-to-child HIV transmission, PMTCT interventions have prevented nearly 22,000 cases of perinatal HIV transmission in the United States since 1994.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27749662      PMCID: PMC5497572          DOI: 10.1097/INF.0000000000001355

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  37 in total

1.  Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.

Authors:  J A Mauskopf; J E Paul; D S Wichman; A D White; H H Tilson
Journal:  JAMA       Date:  1996-07-10       Impact factor: 56.272

2.  Trends in perinatal transmission of HIV/AIDS in the United States.

Authors:  M L Lindegren; R H Byers; P Thomas; S F Davis; B Caldwell; M Rogers; M Gwinn; J W Ward; P L Fleming
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

3.  Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-12-06       Impact factor: 17.586

4.  Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

5.  Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Authors:  Joann Schulte; Ken Dominguez; Thomas Sukalac; Beverly Bohannon; Mary Glenn Fowler
Journal:  Pediatrics       Date:  2007-03-12       Impact factor: 7.124

6.  Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-01       Impact factor: 3.731

7.  Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe.

Authors:  Claire Thorne; Deven Patel; Marie-Louise Newell
Journal:  AIDS       Date:  2004-11-19       Impact factor: 4.177

8.  Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.

Authors:  Béatrice Barret; Marc Tardieu; Pierre Rustin; Catherine Lacroix; Brigitte Chabrol; Isabelle Desguerre; Catherine Dollfus; Marie-Jeanne Mayaux; Stéphane Blanche
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

9.  Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.

Authors:  Valérie Benhammou; Josiane Warszawski; Stéphanie Bellec; François Doz; Nicolas André; Brigitte Lacour; Martine Levine; Françoise Bavoux; Roland Tubiana; Laurent Mandelbrot; Jacqueline Clavel; Stéphane Blanche
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

10.  Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Authors:  Ruth E Tuomala; David E Shapiro; Lynne M Mofenson; Yvonne Bryson; Mary Culnane; Michael D Hughes; M J O'Sullivan; Gwendolyn Scott; Alice M Stek; Diane Wara; Marc Bulterys
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

View more
  11 in total

1.  Growth patterns of uninfected children born to women living with perinatally versus nonperinatally acquired HIV.

Authors:  Wendy Yu; Denise L Jacobson; Paige L Williams; Kunjal Patel; Mitchell E Geffner; Russell B Van Dyke; Deborah Kacanek; Linda A DiMeglio; Jennifer Jao
Journal:  AIDS       Date:  2022-03-15       Impact factor: 4.177

2.  Reproductive Desires and Considerations of HIV-Positive Men in Heterosexual Relationships in New York City.

Authors:  Karolynn Siegel; Étienne Meunier; Jack Ume Tocco; Helen-Maria Lekas
Journal:  AIDS Behav       Date:  2018-06

3.  The experience and management of HIV stigma among HIV-negative adults in heterosexual serodiscordant relationships in New York City.

Authors:  Karolynn Siegel; Étienne Meunier; Helen-Maria Lekas
Journal:  AIDS Care       Date:  2018-02-19

4.  Brief Report: Estimated Incidence of Perinatally Acquired HIV Infection in the United States, 1978-2013.

Authors:  Steven R Nesheim; Jeffrey Wiener; Lauren F Fitz Harris; Margaret A Lampe; Paul J Weidle
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-15       Impact factor: 3.731

5.  Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015.

Authors:  Paige L Williams; Yanling Huo; Richard Rutstein; Rohan Hazra; Kathryn Rough; Russell B Van Dyke; Ellen G Chadwick
Journal:  AIDS Patient Care STDS       Date:  2018-02       Impact factor: 5.078

6.  In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.

Authors:  Shu-Hong Lin; Youjin Wang; Stephen W Hartley; Danielle M Karyadi; Olivia W Lee; Bin Zhu; Weiyin Zhou; Derek W Brown; Erin Beilstein-Wedel; Rohan Hazra; Deborah Kacanek; Ellen G Chadwick; Carmen J Marsit; Miriam C Poirier; Sean S Brummel; Stephen J Chanock; Eric A Engels; Mitchell J Machiela
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.632

Review 7.  Male partner involvement in increasing the uptake of infant antiretroviral prophylaxis/treatment in sub Saharan Africa: A systematic review and meta-analysis.

Authors:  Noah F Takah; Jeannine A Atem; Leopold N Aminde; Moffat Malisheni; Grant Murewenhema
Journal:  BMC Public Health       Date:  2018-02-13       Impact factor: 3.295

8.  Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment.

Authors:  Laura García-Otero; Marta López; Mariona Guitart-Mampel; Constanza Morén; Anna Goncé; Carol Esteve; Laura Salazar; Olga Gómez; Josep María Martínez; Berta Torres; Sergi César; Glòria Garrabou; Fàtima Crispi; Eduard Gratacós
Journal:  PLoS One       Date:  2019-03-04       Impact factor: 3.240

9.  HIV Status and Other Risk Factors for Prevalent and Incident Sexually Transmitted Infection during Pregnancy (2000-2014).

Authors:  Jodie Dionne-Odom; Michelle J Khan; Victoria C Jauk; Jeff Szychowski; Dustin M Long; Suzanne Wallace; Cherry Neely; Karen Fry; Jeanne Marrazzo; Marilyn Crain; Alan T N Tita
Journal:  Infect Dis Obstet Gynecol       Date:  2019-04-01

10.  Substance Use, Demographic and Socioeconomic Factors Are Independently Associated With Postpartum HIV Care Engagement in the Southern United States, 1999-2016.

Authors:  Cassandra Oliver; Peter F Rebeiro; Mary J Hopkins; Beverly Byram; Lavenia Carpenter; Kate Clouse; Jessica L Castilho; William Rogers; Megan Turner; Sally S Bebawy; April C Pettit
Journal:  Open Forum Infect Dis       Date:  2019-01-19       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.